当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析 - 利润表

药明康德

(603259)

77.36

-0.47  (-0.60%)

今开:77.98最高:77.98成交:1.43万手 市盈:0.00 上证指数:2598.82   -0.45%2019-01-22
昨收:77.83 最低:76.54 换手:0.00%振幅:0.00 深证指数:7582.73  -0.57%10:36:08

集合

竞价

利润表

按照会计年度查询:
报告期2018-09-302018-06-302018-03-312017-12-31
一、营业总收入6,921,135,001.684,409,207,1792,141,764,392.117,765,259,856.28
营业收入6,921,135,001.684,409,207,1792,141,764,392.117,765,259,856.28
二、营业总成本5,429,920,918.573,470,226,774.081,794,223,129.776,428,779,845.56
营业成本4,105,515,828.512,642,683,523.021,304,294,322.674,516,794,368.38
营业税金及附加22,242,713.6217,023,281.510,263,262.4525,722,702.2
销售费用233,016,820152,679,970.5872,992,943.69291,509,533.65
管理费用767,659,847.16605,059,024.95269,043,886.61,269,334,048.92
财务费用3,350,960.7259,800,562.54138,328,963.76184,463,115.24
资产减值损失972,558.41-7,019,588.51-700,249.4140,956,077.17
三、其他经营收益-45,589,693.56-22,628,814.37--11,231,029.28
允许价值变动净收益590,231,365.46381,452,524.664,144,872.5677,565.75
投资净收益36,451,586.7759,609,150.73-1,267,961.2439,793,811.63
联营、合营企业投资收益10,887,582.5729,900,060.62-9,773,631.49--
汇兑净收益--------
四、营业利润2,168,865,418.151,415,358,866.37365,311,886.861,460,594,895.77
营业外收入14,591,580.2213,125,820.593,512,380.66135,975,770.68
营业外支出4,727,298.253,453,853.172,831,210.863,950,438.25
非流动资产处置净损失--2,305,477.95----
五、利润总额2,178,729,700.121,425,030,833.79365,993,056.661,592,620,228.2
所得税199,561,718.38120,961,158.2961,775,065.28295,899,689.78
未确认的投资损失--------
六、净利润(百万元)1,928.381,271.9290.661,227.09
少数股东损益50,791,727.7532,172,478.6113,560,391.8469,627,059.12
归属于母公司股东的净利润1,928,376,253.991,271,897,196.89290,657,599.541,227,093,479.3
七、每股收益1.941.310.311.31
基本每股收益1.941.31--1.31
稀释每股收益1.93------
TOP↑